While these are not contraindications to the wellbutrin and tirzepatide combination specifically, autoimmune conditions add variables that require individualized risk assessment and more frequent monitoring
Zhou D, Chen YW, Zhao ZH, Yang RX, Xin FZ, Liu XL, et al
Because tirzepatide drives faster weight loss, it carries slightly higher theoretical gallstone risk during the acute weight loss phase
The guidelines now support exactly that approach
GLP-1 microdosing is suitable for: Individuals at risk for chronic diseases (cardiovascular, neurological, renal) Those pursuing longevity or preventive health measures Patients seeking sustainable wellness beyond weight loss Consultation with your doctor is required to confirm eligibility
Add a third: reduced calorie intake leading to iron and nutrient depletion